 | • レポートコード：D0804-14752 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、107ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アンチセンス治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。アンチセンス治療の種類別市場規模（RNAアンチセンス治療、DNAアンチセンス治療）、用途別市場規模（がん、循環器、HBV、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Alnylam Pharmaceuticals、Benitec Biopharma、Isarna Therapeutics、Ionis Pharmaceuticals, Inc.、Quark Pharmaceuticals、Arbutus Biopharma (Tekmira)、Gradalis、Dicerna Pharmaceuticals、Arrowhead、Sylentis、Sarepta Therapeutics、Biogen ・地域別グローバル市場分析 2015年-2020年 ・アンチセンス治療の北米市場（アメリカ、カナダ、メキシコ） ・アンチセンス治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アンチセンス治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アンチセンス治療の南米市場（ブラジル、アルゼンチン） ・アンチセンス治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：RNAアンチセンス治療、DNAアンチセンス治療 ・用途別分析：がん、循環器、HBV、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Antisense Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Antisense Therapy sales will be xx in 2020 from Antisense Therapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Antisense Therapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Antisense Therapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Antisense Therapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Antisense Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antisense Therapy market has been segmented into:
RNA Antisense Therapy
DNA Antisense Therapy
By Application, Antisense Therapy has been segmented into:
Cancer
Cardiovascular
HBV
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antisense Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Antisense Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antisense Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Antisense Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Antisense Therapy Market Share Analysis
Antisense Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antisense Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antisense Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Antisense Therapy are:
Alnylam Pharmaceuticals
Benitec Biopharma
Isarna Therapeutics
Ionis Pharmaceuticals, Inc.
Quark Pharmaceuticals
Arbutus Biopharma (Tekmira)
Gradalis
Dicerna Pharmaceuticals
Arrowhead
Sylentis
Sarepta Therapeutics
Biogen
Among other players domestic and global, Antisense Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Antisense Therapy Market Overview
1.1 Product Overview and Scope of Antisense Therapy
1.2 Classification of Antisense Therapy by Type
1.2.1 Global Antisense Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antisense Therapy Revenue Market Share by Type in 2019
1.2.3 RNA Antisense Therapy
1.2.4 DNA Antisense Therapy
1.3 Global Antisense Therapy Market by Application
1.3.1 Overview: Global Antisense Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Global Antisense Therapy Market by Regions
1.4.1 Global Antisense Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antisense Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antisense Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antisense Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antisense Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antisense Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antisense Therapy Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Antisense Therapy Industry Impact
1.5.1 COVID-19 Potential Implications for the Antisense Therapy
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Antisense Therapy
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Alnylam Pharmaceuticals Details
2.1.2 Alnylam Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alnylam Pharmaceuticals SWOT Analysis
2.1.4 Alnylam Pharmaceuticals Product and Services
2.1.5 Alnylam Pharmaceuticals Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Benitec Biopharma
2.2.1 Benitec Biopharma Details
2.2.2 Benitec Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Benitec Biopharma SWOT Analysis
2.2.4 Benitec Biopharma Product and Services
2.2.5 Benitec Biopharma Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Isarna Therapeutics
2.3.1 Isarna Therapeutics Details
2.3.2 Isarna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Isarna Therapeutics SWOT Analysis
2.3.4 Isarna Therapeutics Product and Services
2.3.5 Isarna Therapeutics Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ionis Pharmaceuticals, Inc.
2.4.1 Ionis Pharmaceuticals, Inc. Details
2.4.2 Ionis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ionis Pharmaceuticals, Inc. SWOT Analysis
2.4.4 Ionis Pharmaceuticals, Inc. Product and Services
2.4.5 Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Quark Pharmaceuticals
2.5.1 Quark Pharmaceuticals Details
2.5.2 Quark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Quark Pharmaceuticals SWOT Analysis
2.5.4 Quark Pharmaceuticals Product and Services
2.5.5 Quark Pharmaceuticals Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Arbutus Biopharma (Tekmira)
2.6.1 Arbutus Biopharma (Tekmira) Details
2.6.2 Arbutus Biopharma (Tekmira) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Arbutus Biopharma (Tekmira) Product and Services
2.6.4 Arbutus Biopharma (Tekmira) Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gradalis
2.7.1 Gradalis Details
2.7.2 Gradalis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gradalis Product and Services
2.7.4 Gradalis Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dicerna Pharmaceuticals
2.8.1 Dicerna Pharmaceuticals Details
2.8.2 Dicerna Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Dicerna Pharmaceuticals Product and Services
2.8.4 Dicerna Pharmaceuticals Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Arrowhead
2.9.1 Arrowhead Details
2.9.2 Arrowhead Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Arrowhead Product and Services
2.9.4 Arrowhead Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sylentis
2.10.1 Sylentis Details
2.10.2 Sylentis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sylentis Product and Services
2.10.4 Sylentis Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sarepta Therapeutics
2.11.1 Sarepta Therapeutics Details
2.11.2 Sarepta Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sarepta Therapeutics Product and Services
2.11.4 Sarepta Therapeutics Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biogen Product and Services
2.12.4 Biogen Antisense Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antisense Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antisense Therapy Players Market Share
3.2.2 Top 10 Antisense Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antisense Therapy Revenue and Market Share by Regions
4.2 North America Antisense Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Antisense Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antisense Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Antisense Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antisense Therapy Revenue and Growth Rate (2015-2020)
5 North America Antisense Therapy Revenue by Countries
5.1 North America Antisense Therapy Revenue by Countries (2015-2020)
5.2 USA Antisense Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Antisense Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Antisense Therapy Revenue and Growth Rate (2015-2020)
6 Europe Antisense Therapy Revenue by Countries
6.1 Europe Antisense Therapy Revenue by Countries (2015-2020)
6.2 Germany Antisense Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Antisense Therapy Revenue and Growth Rate (2015-2020)
6.4 France Antisense Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Antisense Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Antisense Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antisense Therapy Revenue by Countries
7.1 Asia-Pacific Antisense Therapy Revenue by Countries (2015-2020)
7.2 China Antisense Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Antisense Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Antisense Therapy Revenue and Growth Rate (2015-2020)
7.5 India Antisense Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antisense Therapy Revenue and Growth Rate (2015-2020)
8 South America Antisense Therapy Revenue by Countries
8.1 South America Antisense Therapy Revenue by Countries (2015-2020)
8.2 Brazil Antisense Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Antisense Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antisense Therapy by Countries
9.1 Middle East & Africa Antisense Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antisense Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Antisense Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Antisense Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Antisense Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antisense Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Antisense Therapy Market Forecast by Type (2019-2024)
10.3 RNA Antisense Therapy Revenue Growth Rate (2015-2025)
10.4 DNA Antisense Therapy Revenue Growth Rate (2015-2025)
11 Global Antisense Therapy Market Segment by Application
11.1 Global Antisense Therapy Revenue Market Share by Application (2015-2020)
11.2 Antisense Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Cardiovascular Revenue Growth (2015-2020)
11.5 HBV Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Antisense Therapy Market Size Forecast (2021-2025)
12.1 Global Antisense Therapy Market Size Forecast (2021-2025)
12.2 Global Antisense Therapy Market Forecast by Regions (2021-2025)
12.3 North America Antisense Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Antisense Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antisense Therapy Revenue Market Forecast (2021-2025)
12.6 South America Antisense Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antisense Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Antisense Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antisense Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antisense Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antisense Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Antisense Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Alnylam Pharmaceuticals Corporate Information, Location and Competitors
Table 7. Alnylam Pharmaceuticals Antisense Therapy Major Business
Table 8. Alnylam Pharmaceuticals Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Alnylam Pharmaceuticals SWOT Analysis
Table 10. Alnylam Pharmaceuticals Antisense Therapy Product and Solutions
Table 11. Alnylam Pharmaceuticals Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Benitec Biopharma Corporate Information, Location and Competitors
Table 13. Benitec Biopharma Antisense Therapy Major Business
Table 14. Benitec Biopharma Antisense Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Benitec Biopharma SWOT Analysis
Table 16. Benitec Biopharma Antisense Therapy Product and Solutions
Table 17. Benitec Biopharma Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Isarna Therapeutics Corporate Information, Location and Competitors
Table 19. Isarna Therapeutics Antisense Therapy Major Business
Table 20. Isarna Therapeutics Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Isarna Therapeutics SWOT Analysis
Table 22. Isarna Therapeutics Antisense Therapy Product and Solutions
Table 23. Isarna Therapeutics Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Ionis Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 25. Ionis Pharmaceuticals, Inc. Antisense Therapy Major Business
Table 26. Ionis Pharmaceuticals, Inc. Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Ionis Pharmaceuticals, Inc. SWOT Analysis
Table 28. Ionis Pharmaceuticals, Inc. Antisense Therapy Product and Solutions
Table 29. Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Quark Pharmaceuticals Corporate Information, Location and Competitors
Table 31. Quark Pharmaceuticals Antisense Therapy Major Business
Table 32. Quark Pharmaceuticals Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Quark Pharmaceuticals SWOT Analysis
Table 34. Quark Pharmaceuticals Antisense Therapy Product and Solutions
Table 35. Quark Pharmaceuticals Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Arbutus Biopharma (Tekmira) Corporate Information, Location and Competitors
Table 37. Arbutus Biopharma (Tekmira) Antisense Therapy Major Business
Table 38. Arbutus Biopharma (Tekmira) Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Arbutus Biopharma (Tekmira) SWOT Analysis
Table 40. Arbutus Biopharma (Tekmira) Antisense Therapy Product and Solutions
Table 41. Arbutus Biopharma (Tekmira) Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Gradalis Corporate Information, Location and Competitors
Table 43. Gradalis Antisense Therapy Major Business
Table 44. Gradalis Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Gradalis SWOT Analysis
Table 46. Gradalis Antisense Therapy Product and Solutions
Table 47. Gradalis Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Dicerna Pharmaceuticals Corporate Information, Location and Competitors
Table 49. Dicerna Pharmaceuticals Antisense Therapy Major Business
Table 50. Dicerna Pharmaceuticals Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Dicerna Pharmaceuticals SWOT Analysis
Table 52. Dicerna Pharmaceuticals Antisense Therapy Product and Solutions
Table 53. Dicerna Pharmaceuticals Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Arrowhead Corporate Information, Location and Competitors
Table 55. Arrowhead Antisense Therapy Major Business
Table 56. Arrowhead Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Arrowhead SWOT Analysis
Table 58. Arrowhead Antisense Therapy Product and Solutions
Table 59. Arrowhead Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Sylentis Corporate Information, Location and Competitors
Table 61. Sylentis Antisense Therapy Major Business
Table 62. Sylentis Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 63. Sylentis SWOT Analysis
Table 64. Sylentis Antisense Therapy Product and Solutions
Table 65. Sylentis Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Sarepta Therapeutics Corporate Information, Location and Competitors
Table 67. Sarepta Therapeutics Antisense Therapy Major Business
Table 68. Sarepta Therapeutics Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 69. Sarepta Therapeutics SWOT Analysis
Table 70. Sarepta Therapeutics Antisense Therapy Product and Solutions
Table 71. Sarepta Therapeutics Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Biogen Corporate Information, Location and Competitors
Table 73. Biogen Antisense Therapy Major Business
Table 74. Biogen Antisense Therapy Total Revenue (USD Million) (2017-2018)
Table 75. Biogen SWOT Analysis
Table 76. Biogen Antisense Therapy Product and Solutions
Table 77. Biogen Antisense Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Antisense Therapy Revenue (Million USD) by Players (2015-2020)
Table 79. Global Antisense Therapy Revenue Share by Players (2015-2020)
Table 80. Global Antisense Therapy Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Antisense Therapy Revenue Market Share by Regions (2015-2020)
Table 82. North America Antisense Therapy Revenue by Countries (2015-2020)
Table 83. North America Antisense Therapy Revenue Market Share by Countries (2015-2020)
Table 84. Europe Antisense Therapy Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Antisense Therapy Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Antisense Therapy Revenue by Countries (2015-2020)
Table 87. South America Antisense Therapy Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Antisense Therapy Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Antisense Therapy Revenue Market Share by Countries (2015-2020)
Table 90. Global Antisense Therapy Revenue (Million USD) by Type (2015-2020)
Table 91. Global Antisense Therapy Revenue Share by Type (2015-2020)
Table 92. Global Antisense Therapy Revenue Forecast by Type (2021-2025)
Table 93. Global Antisense Therapy Revenue by Application (2015-2020)
Table 94. Global Antisense Therapy Revenue Share by Application (2015-2020)
Table 95. Global Antisense Therapy Revenue Forecast by Application (2021-2025)
Table 96. Global Antisense Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antisense Therapy Picture
Figure 2. Global Antisense Therapy Revenue Market Share by Type in 2019
Figure 3. RNA Antisense Therapy Picture
Figure 4. DNA Antisense Therapy Picture
Figure 5. Antisense Therapy Revenue Market Share by Application in 2019
Figure 6. Cancer Picture
Figure 7. Cardiovascular Picture
Figure 8. HBV Picture
Figure 9. Other Picture
Figure 10. Global Antisense Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Antisense Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Antisense Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Antisense Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Antisense Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Antisense Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Antisense Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Antisense Therapy Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Antisense Therapy Revenue Market Share in 2019
Figure 19. Global Top 10 Players Antisense Therapy Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Antisense Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Antisense Therapy Revenue Market Share by Regions (2015-2020)
Figure 23. Global Antisense Therapy Revenue Market Share by Regions in 2018
Figure 24. North America Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Europe Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 27. South America Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 29. North America Antisense Therapy Revenue Market Share by Countries (2015-2020)
Figure 30. North America Antisense Therapy Revenue Market Share by Countries in 2019
Figure 31. USA Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Canada Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Europe Antisense Therapy Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Antisense Therapy Revenue Market Share by Countries in 2019
Figure 36. Germany Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 37. UK Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 38. France Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Russia Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Italy Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antisense Therapy Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Antisense Therapy Revenue Market Share by Countries in 2019
Figure 43. China Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Japan Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Korea Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 46. India Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 48. South America Antisense Therapy Revenue Market Share by Countries (2015-2020)
Figure 49. South America Antisense Therapy Revenue Market Share by Countries in 2019
Figure 50. Brazil Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Antisense Therapy Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Antisense Therapy Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 55. UAE Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Antisense Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Global Antisense Therapy Revenue Share by Type (2015-2020)
Figure 59. Global Antisense Therapy Revenue Share by Type in 2019
Figure 60. Global Antisense Therapy Market Share Forecast by Type (2021-2025)
Figure 61. Global RNA Antisense Therapy Revenue Growth Rate (2015-2020)
Figure 62. Global DNA Antisense Therapy Revenue Growth Rate (2015-2020)
Figure 63. Global Antisense Therapy Revenue Share by Application (2015-2020)
Figure 64. Global Antisense Therapy Revenue Share by Application in 2019
Figure 65. Global Antisense Therapy Market Share Forecast by Application (2021-2025)
Figure 66. Global Cancer Revenue Growth Rate (2015-2020)
Figure 67. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 68. Global HBV Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Antisense Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Antisense Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Antisense Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Antisense Therapy Revenue Market Forecast (2021-2025)
Figure 74. Europe Antisense Therapy Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Antisense Therapy Revenue Market Forecast (2021-2025)
Figure 76. South America Antisense Therapy Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Antisense Therapy Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
パラフィン理学療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Paraffin Physical Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Paraffin Physical T…- ミリ波治療器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Millimeter Wave Therapy Instrument market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Millimeter…
- 放射線療法用QAシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Radiation Therapy QA Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Radiation Therap…
- 圧迫着衣療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Compression Clothing Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Compression Clot…
- 継続型腎代替療法（CRRT）マシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Continuous Renal Replacement Therapy (CRRT) Machine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…